Latest Convertible Notes News

Visionflex Group Limited reported a mixed quarter with a modest cash burn but strengthened its balance sheet through a significant debt-to-equity conversion and maintained solid funding capacity.

Foresta Group Holdings has updated its share registry provider, extended its technology license with E3 Carbon, and deferred earthworks at its Kawerau project to Q3 2026, while maintaining a solid cash position.

BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.

Global Masters Fund Limited reports steady convertible note activity and a robust loan-to-value ratio of 9.36% for the December 2025 quarter, underscoring its solid financial footing.

Flagship Investments Limited has confirmed stable financial metrics for its convertible notes in the December 2025 quarter, maintaining a conservative loan-to-value ratio and full compliance with regulatory requirements.

ECP Emerging Growth Limited has reported steady financial health for its convertible notes, maintaining a 28.03% loan-to-value ratio and full compliance with regulatory requirements for the quarter ending December 2025.

Noble Helium has restructured its VAT shortfall loan, extending maturity to mid-2027 and raising $2.15 million through a convertible loan note to support its strategic turnaround and Rukwa drilling program.

Osteopore Limited has completed the full subscription of Tranche 1 under its A$20 million convertible notes facility, raising an additional A$250,000 to support ongoing business and future projects.

Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.

Eden Innovations has secured a $2.2 million strategic investment to fully repay its remaining iBorrow debt, eliminating costly interest payments and strengthening its balance sheet ahead of anticipated revenue growth.

Imagion Biosystems has completed the conversion of its first tranche convertible notes with Mercer Street, issuing over 3 million shares, while renegotiating terms on the second tranche to extend maturity and reduce debt.

Fatfish Group Limited has refinanced its $5.67 million debt with Arena Investors LP and secured an additional $0.15 million through new convertible notes, including a board nomination right for Arena.